Phase I clinical study of irinotecan (CPT-11) in combination with UFT/folinic acid (FA) in patients with advanced colorectal cancer (CRC).

被引：0
|
作者：
Paz-Ares, L
Garcia-Alfonso, P
Castellanos, D
Martin, B
Perez-Manga, G
Cortes-Funes, H
Gonzalez, J
Gravalos, C
机构：
[1] Univ Madrid, Hosp Doce Octubre, Madrid 3, Spain
[2] Hosp Gen Gregorio Maranon, Madrid, Spain
[3] Aventis, Madrid, Spain
来源：
CLINICAL CANCER RESEARCH | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
543
引用
收藏
页码：4575S / 4575S
页数：1
相关论文
共 50 条
  • [1] Phase I trial of escalating doses of irinotecan (CPT-11) in combination with UFT/folinic acid (FA) in patients with advanced colorectal cancer (CRC).
    Gravalos, C
    Garcia-Alfonso, P
    Castellanos, D
    Martin, B
    Perez-Manga, G
    Cortes-Funes, H
    Gonzalez-Lama, J
    Paz-Ares, L
    ANNALS OF ONCOLOGY, 2000, 11 : 46 - 46
  • [2] A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer
    Manabu Shiozawa
    Nobuhiro Sugano
    Kazuhito Tsuchida
    Soichiro Morinaga
    Makoto Akaike
    Yukio Sugimasa
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 365 - 370
  • [3] A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer
    Shiozawa, Manabu
    Sugano, Nobuhiro
    Tsuchida, Kazuhito
    Morinaga, Soichiro
    Akaike, Makoto
    Sugimasa, Yukio
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (03) : 365 - 370
  • [4] Irinotecan (CPT-11) in pretreated metastatic colorectal cancer (CRC)
    Lara, MA
    Feliu, J
    Salinas, P
    Fernandez, Y
    Garcia-Giron, C
    ANNALS OF ONCOLOGY, 1998, 9 : 45 - 46
  • [5] Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer
    Tsunoda, A.
    Yasuda, N.
    Nakao, K.
    Narita, K.
    Yamazaki, K.
    Watanabe, M.
    Suzuki, N.
    Kusano, M.
    ONCOLOGY, 2007, 72 (1-2) : 58 - 63
  • [6] Phase I of CPT-11 (CAMPTO®) combined with 5-FU/folinic acid (FA) nordic schedule in first line metastatic colorectal cancer (CRC)
    Ristamäki, R
    Glimelius, B
    Linné, T
    Boussard, B
    Oulid-Aïssa, D
    Pyrhonen, S
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S79 - S79
  • [7] A combination phase I study of amrubicin and irinotecan (CPT-11) in patients with lung cancer.
    Kurata, T
    Kaneda, H
    Tamura, K
    Satoh, T
    Nogami, T
    Uejima, H
    Nakagawa, K
    Fukuoka, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 703S - 703S
  • [8] A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer
    Heather Wakelee
    George A. Fisher
    Investigational New Drugs, 2005, 23 : 241 - 242
  • [9] A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer
    Wakelee, H
    Fisher, GA
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (03) : 241 - 242
  • [10] Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients
    Koji Okabayashi
    Hirotoshi Hasegawa
    Yoshiyuki Ishii
    Takashi Endo
    Hiroki Ochiai
    Tetsuro Kubota
    Yuko Kitagawa
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 501 - 507
12345